Kirske David's Form 4 filing
Cti Biopharma Corp (CTIC) · filed Oct 6, 2022
- Accession no.
- 0000891293-22-000047
- Filed
- Oct 6, 2022
- Trade date
- Oct 4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $13.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirske DavidCIK 0001276750 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | common stock | MOption exerciseAcquired | +1,400 | $0.95 | +$1,330 | 18,313 | Direct | |
| Oct 4, 2022 | common stock | SSaleDisposed | −1,400 | $6.25 | −$8,750 | 16,913 | Direct | |
| Oct 4, 2022 | common stock | MOption exerciseAcquired | +100 | $0.95 | +$95 | 17,013 | Direct | |
| Oct 4, 2022 | common stock | SSaleDisposed | −100 | $6.26 | −$626 | 16,913 | Direct | |
| Oct 4, 2022 | common stock | MOption exerciseAcquired | +609 | $0.95 | +$578.55 | 17,522 | Direct | |
| Oct 4, 2022 | common stock | SSaleDisposed | −609 | $6.27 | −$3,818.43 | 16,913 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | Common Stock | MOption exerciseDisposed | −1,400 | $0.00 | $0 | 324,967 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 324,867 | Direct | |
| Oct 4, 2022 | Common Stock | MOption exerciseDisposed | −609 | $0.00 | $0 | 324,258 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.